📰 Sciences Stock Performance News
Sciences Stock Performance News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sciences Stock Performance. Real-time updates on events, politics, business and more.
June 4, 2024
Rhenman & Partners Asset Management AB boosted its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 3.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 165,000 shares of the medical research company’s stock after acquiring an additional 5,000 shares during […]
May 27, 2024
StockNews.com initiated coverage on shares of Applied DNA Sciences (NASDAQ:APDN – Free Report) in a report issued on Thursday. The firm issued a hold rating on the technology company’s stock. Separately, HC Wainwright increased their price objective on Applied DNA Sciences from $1.50 to $7.00 and gave the stock a buy rating in a research […]
April 27, 2024
Motley Fool Asset Management LLC cut its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.6% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,931 shares of the medical research company’s stock after selling 310 shares during the quarter. […]
April 7, 2024
Silvant Capital Management LLC lowered its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 13.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,119 shares of the medical research company’s stock after selling 2,181 […]
April 6, 2024
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) EVP Sarah Condella sold 2,000 shares of the stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $70.00, for a total transaction of $140,000.00. Following the completion of the sale, the executive vice president now directly owns […]
April 2, 2024
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 6,520,000 shares, a drop of 7.4% from the February 29th total of 7,040,000 shares. Based on an average trading volume of 1,940,000 shares, the short-interest ratio […]
April 2, 2024
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 6,520,000 shares, a drop of 7.4% from the February 29th total of 7,040,000 shares. Based on an average trading volume of 1,940,000 shares, the short-interest ratio […]
February 29, 2024
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) EVP Sarah Condella sold 1,021 shares of the stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $59.72, for a total value of $60,974.12. Following the transaction, the executive vice president now owns 71,658 shares of the company’s stock, […]
February 28, 2024
Exact Sciences Co. (NASDAQ:EXAS – Free Report) – Investment analysts at Leerink Partnrs boosted their Q1 2024 EPS estimates for Exact Sciences in a research note issued to investors on Wednesday, February 21st. Leerink Partnrs analyst P. Souda now anticipates that the medical research company will earn ($0.36) per share for the quarter, up from […]
February 23, 2024
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) Director D Scott Coward sold 706 shares of the stock in a transaction on Wednesday, February 21st. The shares were sold at an average price of $61.50, for a total transaction of $43,419.00. Following the completion of the transaction, the director now directly owns 43,122 shares in […]